Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Recommendations for diagnosis and management of multiple sclerosis.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Biomarkers in multiple sclerosis.
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
[Cannabinoid drugs for neurological diseases: what is behind?].
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
Pages
« first
‹ previous
…
175
176
177
178
179
180
181
182
183
…
next ›
last »